Gut health boost: could probiotics help control MS?

NCT ID NCT07168772

First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests whether taking a daily probiotic supplement for six months can improve immune function in people with relapsing-remitting multiple sclerosis (MS). Eighty adults aged 18-55 will be randomly assigned to receive either the probiotic or a placebo, alongside their usual MS medication. The main goal is to see if the probiotic increases a type of immune cell (Treg cells) that helps control inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Probiotic supplement (Lactibane Iki) containing Bifidobacterium lactis, Lactobacillus acidophilus, and Lactobacillus salivarius
What this could lead to
If it works, this could point toward a simple, safe way to improve immune balance in multiple sclerosis patients already on standard therapy.
What could go wrong
This is a small, early-stage trial focused on immune markers, not clinical symptoms. The probiotic may show no benefit or cause digestive upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre d'Esclerosi Mútiple de Catalunya (Cemcat)

    RECRUITING

    Barcelona, Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.